ACME UNITED CORP - 10-Q Summary (Q3 2024)
Business Context and Reporting Period
This is a Quarterly Report on Form 10-Q for ACME UNITED CORP for the period ended September 30, 2024. The company manufactures and distributes first aid, medical, cutting, and sharpening products. It operates in three reportable segments: United States, Canada, and Europe. The company is classified as an accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric | Q3 2024 (3 Months) | Q3 2023 (3 Months) | YTD 2024 (9 Months) | YTD 2023 (9 Months) |
|---|---|---|---|---|
| Net Sales | $48.2M | $50.4M | $148.5M | $149.6M |
| Gross Profit | $18.6M (38.5%) | $19.5M (38.7%) | $58.6M (39.4%) | $55.8M (37.3%) |
| Operating Income | $2.9M | $3.7M | $11.9M | $11.1M |
| Net Income | $2.2M | $2.2M | $8.3M | $6.6M |
| Diluted EPS | $0.54 | $0.58 | $2.03 | $1.83 |
| Cash from Operations (YTD) | $5.6M (vs $21.7M YTD 2023) | |||
| Total Debt (Long-term + Current) | $32.5M (Sep 30, 2024) | |||
| Working Capital | $76.4M (Sep 30, 2024) |
Material Changes vs. Prior Period
- Revenue: Consolidated net sales decreased 4% in Q3 and 1% YTD compared to 2023. However, excluding the Camillus and Cuda product lines (sold in Nov 2023), sales increased 4% in Q3 and 5% YTD.
- Profitability: Gross margin improved YTD to 39.4% from 37.3% due to manufacturing productivity improvements. Operating income increased 7% YTD despite higher SG&A expenses driven by personnel costs.
- Segment Performance:
- U.S.: Sales down 6% in Q3 (up 3% excluding divestitures); Operating income down $0.6M in Q3 but up $1.2M YTD.
- Europe: Sales up 10% in Q3 and 6% YTD due to market share gains in the office channel.
- Canada: Sales down 1% in Q3 (up 2% in local currency); Operating income declined YTD due to soft demand for school/office products.
- Debt: Long-term debt increased significantly to $22.0M (from $13.1M at year-end 2023) primarily to fund the acquisition of Elite First Aid, Inc.
- Cash Flow: Operating cash flow decreased significantly YTD ($5.6M vs $21.7M) due to a $5.3M increase in accounts receivable and a $5.1M decrease in accounts payable.
Guidance, Outlook, Risks, and Unusual Items
- Acquisition: On May 23, 2024, the company acquired Elite First Aid, Inc. for approximately $7.1M. The purchase price includes $1.0M in holdbacks/contingent payments.
- Divestiture Impact: The sale of Camillus and Cuda hunting/fishing lines in late 2023 negatively impacted Q3 2024 comparisons as those lines are highly seasonal in Q3.
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of September 30, 2024, due to a material weakness in IT general controls (change management and logical controls). Remediation is expected to be completed by December 31, 2024.
- Risks: Key risks include global economic conditions, inflation, supply chain disruptions, international trade policies/tariffs, and currency fluctuations.
- Liquidity: The company maintains a $65M revolving credit facility with $42.9M available as of September 30, 2024. Management believes cash flow and available credit are sufficient for the next 12 months.
Investor Verification Checklist
- Internal Control Remediation: Verify the timeline and effectiveness of the remediation plan for the identified material weakness in IT controls.
- Acquisition Integration: Monitor the financial performance and integration progress of the Elite First Aid acquisition.
- Debt Covenants: Confirm continued compliance with debt covenants (funded debt to EBITDA, fixed charge coverage) given the increased debt load.
- Working Capital Trends: Investigate the drivers behind the significant increase in accounts receivable and decrease in accounts payable, which impacted operating cash flow.
- Divestiture Adjustments: Review future guidance to ensure it appropriately reflects the permanent loss of the Camillus and Cuda revenue streams.